Author

Erin Connolly-Strong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:variant calling· 4 Assay:whole-genome sequencing· 4 Organism:human· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Research Focus:variant effect prediction· 2

Frequent Co-Authors

Brian Baek-Lok Oh· 4 shared Sangmoon LeeiD· 4 shared Jung‐Ah KimiD· 3 shared Hansol ParkiD· 2 shared Hyun Woo LeeiD· 2 shared Jaemo Koo· 2 shared Jang‐Hee KimiD· 2 shared Jeonghoon Lee· 2 shared

Activity by Year

2023-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetic & Genomic Medicine

Brian Baek-Lok Oh

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Analytical and clinical validation of a genome sequencing-based comprehensive rare disease genomic profiling test.

Shruthi Sriram, Sang‐Yeon Lee, Stephanie Ferguson, June‐Young Koh, Jonathan Kyle Wallace, Jeonghoon Lee, Jung‐Ah Kim, Yoonsuh Lee, Brian Baek-Lok Oh, Won Chul Lee, Sangmoon Lee, Erin Connolly-Strong

This study validates a whole-genome sequencing assay for rare disease genomic profiling, showing high sensitivity and positive predictive values for variant detection.

medRxiv · Oct 19, 2024 · PreprintGenetic & Genomic Medicine

Target-enhanced whole-genome sequencing (TE-WGS) shows clinical validity equivalent to commercially available targeted oncology panel

Sangmoon Lee, Jin Roh, Jun Sung Park, İslam Oğuz Tuncay, Won‐Chul Lee, Jung‐Ah Kim, Brian Baek-Lok Oh, Jong-Yeon Shin, Jeong Seok Lee, Young Seok Ju, Ryul Kim, Seongyeol Park, Jaemo Koo, Hansol Park, Joonoh Lim, , Minsuk Kwon

This study compares target-enhanced whole-genome sequencing (TE-WGS) with a commercial targeted panel, showing TE-WGS detects all variants and provides additional clinical insights.

Cancer Research and Treatment · Sep 19, 2024Peer-reviewedGenetic & Genomic Medicine

Clinical application of whole-genome sequencing for precision oncology of solid tumors

Ryul Kim, Seokhwi Kim, Brian Baek-Lok Oh, Woo Sik Yu, Chang Woo Kim, Hoon Hur, Sang‐Yong Son, Min Jae Yang, Dae Sung Cho, Taeyang Ha, Subin Heo, Jeon Yeob Jang, Jae Sung Yun, Kyu‐Sung Kwack, Jai Keun Kim, , Minsuk Kwon

This study evaluates the clinical utility of whole-genome sequencing in solid tumors, showing 72% of reports provided clinically relevant insights and 69% aided therapeutic decision-making.

Experimental & Molecular Medicine · Aug 13, 2024Peer-reviewedGenetic & Genomic Medicine

Analytical and clinical validation of a targeted-enhanced whole genome sequencing-based comprehensive genomic profiling test.

Stephanie Ferguson, Shruthi Sriram, Jonathan Kyle Wallace, Jeonghoon Lee, Jung‐Ah Kim, Yoonsuh Lee, Brian Baek-Lok Oh, Won Chul Lee, Sangmoon Lee, Erin Connolly-Strong

The paper validates a targeted-enhanced whole-genome sequencing assay for oncology genomic profiling, showing high sensitivity and specificity for SNVs and indels, and high concordance with reference methods.

medRxiv · Dec 18, 2023 · PreprintGenetic & Genomic Medicine